Results 211 to 220 of about 1,672,248 (364)
AMINO ACID STUDIES. II. PLASMA AMINO ACID RETENTION, AS EVIDENCE OF IMPAIRED LIVER FUNCTION. INVESTIGATIONS IN CHILDREN WITH NEPHROSIS AND LIVER DISEASE 1 [PDF]
John D. Lyttle+4 more
openalex +1 more source
Ayurvedic treatment outcome for Chronic Liver diseases [PDF]
Currently available medical therapies for liver disorders have more systemic toxicity, cost effective and liver transplantation was advised to many cases. So many patients want to take ayurveda medication as last choice or as a choice due to poverty.
Dr. Ashok Kumar Panda, Dr. K. K. Rath
core +1 more source
Alcoholic-associated liver disease (ALD) and metabolic dysfunction-associated steatotic liver disease (MASLD) show a high prevalence rate worldwide. As gut microbiota represents current state of ALD and MASLD via gut-liver axis, typical characteristics ...
In-gyu Park+6 more
doaj +1 more source
LIVER VITAMIN B12 LEVELS IN CHRONIC LIVER DISEASES
Nobuo Kato+2 more
openalex +2 more sources
Inflammation in Liver Diseases [PDF]
Dechun Feng+3 more
openaire +4 more sources
THE ELIMINATION OF CHOLIC ACIDS. IV. IN PATIENTS WITH LIVER DISEASES 1 [PDF]
Bertil Josephson
openalex +1 more source
We provide a step‐by‐step guide for producing E140 antigen fragments from Plasmodium berghei (Pb1) and Plasmodium vivax (Pv1). Pb1/Pv1 are expressed in E. coli, solubilized by freeze–thawing, refolded by slow dilution, purified by affinity chromatography (IMAC), then concentrated and subjected to quality control.
Rodolfo Ferreira Marques+5 more
wiley +1 more source
Osimertinib reduces angiogenesis and PDL1 expression in in ovo tumors, transforming them into ‘cold tumors’ with lower immune activity. Anatomopathological and transcriptomic analyses highlight its therapeutic impact on tumor biology. This study underscores osimertinib's potential to reshape the tumor microenvironment and provides insights into its ...
David Barthélémy+14 more
wiley +1 more source